Loading...
Loading...
By Sergio Arturo Lievano Madrigal - Thu, 08/13/2026 - 15:57
This week, AI reshaped clinical care, COFEPRIS reset priorities, and new hospital investments advanced. This and more in the weekly roundup!
https://mexicobusiness.news/tag/rare-diseases
More Health
By David López García - Wed, 08/12/2026 - 07:00
Caregivers are essential to rare disease care, managing financial toxicity, advocacy, and health equity challenges, writes David López García.
By Sergio Arturo Lievano Madrigal - Fri, 07/17/2026 - 13:47
This week: out-of-pocket spending jumps 41%, obesity policy advances on multiple fronts, and the EU deal boosts medical device exports.
By Jorge Melendez Zajgla - Tue, 07/14/2026 - 06:00
Mexico must close its rare disease diagnostic gap using genomics and registries to optimize healthcare costs, writes Jorge Meléndez.
By Sergio Arturo Lievano Madrigal - Wed, 06/10/2026 - 16:03
Mexico advances healthcare resilience through pharmaceutical sovereignty, rare disease care, and AI-driven innovation. This is The Week in Health!
By David López García - Tue, 06/09/2026 - 08:00
Multidisciplinary care and clinical genetics improve patient outcomes, healthcare efficiency, and rare disease management, writes David López.
By David López García - Tue, 04/07/2026 - 06:30
The journey of an orphan drug from the lab to the patient is long, but it offers an opportunity to transform healthcare systems, writes David López.
By Aura Moreno - Fri, 02/27/2026 - 11:46
Mexico ties World Cup 2026 to public health, boosts maternal care, and confronts insurance and rare disease gaps. This is The Week in Health!
By Aura Moreno - Thu, 02/26/2026 - 14:41
The FDA’s qualification of hip bone mineral density as a surrogate endpoint is expected to reshape osteoporosis drug development.
By Aura Moreno - Tue, 02/24/2026 - 08:13
Diagnostic delays and uneven access highlight structural gaps in Mexico’s rare disease care and policy framework.
By MBN Staff - Mon, 01/19/2026 - 08:46
Multicare and KalVista partner to expand access to the first oral on-demand treatment for hereditary angioedema (HAE) across Latin America.
